{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P28906",
      "entity_text" : "CD34",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-1001" ],
      "Cellular_component" : [ "uniprot:SL-0487" ],
      "Organ" : [ "uberon:UBERON:0000468" ],
      "Species" : [ "taxonomy:9606" ],
      "CellType" : [ "cl:CL:0000084" ]
    }
  },
  "verbose_text" : "In all three cases, between 5-6% of donor T cells were modified (XREF_FIG) ensuring low vector copy numbers and these cells were then enriched on the basis of CD34 expression to 92-96% purity to produce target cell doses for infusion (XREF_FIG).",
  "reading_complete" : "2020-08-08T11:05:02Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T11:04:00Z",
  "trigger" : "expression",
  "evidence" : [ "CD34 expression" ],
  "pmc_id" : "3804528",
  "score" : 0
}